transthoracic device closure of atrial septal defect相关文献:
Advances in the management of cardioembolic stroke associated with patent foramen ovale.
Mac Grory B, Ohman EM, Feng W, Xian Y, Yaghi S, Kamel H, Reznik ME.
BMJ. 2022 Feb 9;376:e063161. doi: 10.1136/bmj-2020-063161.
PMID:35140114
Outcomes and complications of percutaneous device closure in adults with secundum atrial septal defect.
Bashir F, Hameed M, Hanif B, Aijaz S.
J Pak Med Assoc. 2022 Feb;72(2):385-389. doi: 10.47391/JPMA.106.
PMID:35320204
Complex atrial septal defect closure in children.
Mahmoud H, Nicolescu AM, Filip C, Nicolae G, Duică G, Bălgrădean M, Cinteză EE.
Rom J Morphol Embryol. 2019;60(1):49-57.
PMID:31263827
Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up.
Snijder RJR, Renes LE, Bosshardt D, Suttorp MJ, Ten Berg JM, Post MC.
J Interv Cardiol. 2020 Feb 14;2020:7136802. doi: 10.1155/2020/7136802. eCollection 2020.
PMID:32140088
Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh.
Saha SK, Ahmed CM, Haque T, Al Mamun MA, Hussain MZ.
Feasibility of Device Closure for Multiple Atrial Septal Defects With an Inferior Sinus Venosus Defect: Procedural Planning Using Three-Dimensional Printed Models.